Insider Stock Trading History of Moore John R


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Moore John R since year 2005. The trader's CIK number is 1191702. At the time of this reporting, Moore John R is the VP, General Counsel of Array Biopharma Inc . (stock ticker symbol ARRY). See this page for all insider trading activities at Array Biopharma Inc .


Stock purchases, sales, and option exercises reported by insider Moore John R since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-04-01 ARRY Array Biopharma Inc Option Ex 6,718 .00 0
2015-03-01 ARRY Array Biopharma Inc Option Ex 22,906 7.96 182,331
2013-11-29 ARRY Array Biopharma Inc Sale 11,666 5.79 67,546
2013-11-13 ARRY Array Biopharma Inc Sale 200 5.79 1,158
2013-08-01 ARRY Array Biopharma Inc Sale 31,500 7.00 220,626
2013-08-02 ARRY Array Biopharma Inc Option Ex 43,884 3.04 133,187
2013-08-01 ARRY Array Biopharma Inc Option Ex 26,741 2.88 76,880
2013-08-02 ARRY Array Biopharma Inc Sale 43,884 7.03 308,460
2013-07-23 ARRY Array Biopharma Inc Option Ex 5,000 2.74 13,700
2013-07-23 ARRY Array Biopharma Inc Sale 5,000 6.50 32,500
2013-07-25 ARRY Array Biopharma Inc Option Ex 4,759 3.75 17,846
2013-04-23 ARRY Array Biopharma Inc Option Ex 20,000 2.74 54,800
2012-10-08 ARRY Array Biopharma Inc Sale 28,547 5.69 162,318
2011-04-05 ARRY Array Biopharma Inc Sale 356 3.30 1,174
2011-01-10 ARRY Array Biopharma Inc Sale 593 3.30 1,956
2011-01-11 ARRY Array Biopharma Inc Sale 2,366 3.30 7,807
2011-01-06 ARRY Array Biopharma Inc Sale 24,039 3.25 78,126
2010-10-05 ARRY Array Biopharma Inc Sale 20,067 3.29 66,020
2010-08-03 ARRY Array Biopharma Inc Sale 3,479 3.25 11,306
2010-08-02 ARRY Array Biopharma Inc Sale 2,840 3.25 9,230
2006-11-20 ARRY Array Biopharma Inc Option Ex 24,858 6.30 156,679
2006-11-20 ARRY Array Biopharma Inc Sale 27,263 13.04 355,509
2006-02-17 ARRY Array Biopharma Inc Sale 4,456 9.38 41,797

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moore John R (VP, General Counsel of Array Biopharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.